
US Patent Application No: 2004/0082,642
Number of patents in Portfolio can not be more than 2000
Novel estrogen receptor ligands and method III
Stats
-
Apr 29, 2004
Publication date -
Nov 14, 2003
filing date -
10/433,271
serial no -
ABAN
status
Importance
Abstract
The present invention relates to compounds of formula (I) and derivatives thereof, in which the variables are as defined in the claims, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restinosis, gynecomastia, autoimmune disease, vascular smooth muscle cell profileration, obesity, incontinence, and cancer of the lung, colon, breast, uterus, and prostate.
First Claim
Related Publications
International Classification(s)
- [Classification Symbol]
- [Patents Count]